Dr. Smith Joseph , DO
Internal Medicine • North Miami, FL
13377 W Dixie Hwy
North Miami, FL 331614134
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Smith Joseph is listed in NPPES under Internal Medicine.
-
NPI assigned on December 14, 2005; this date does not establish years in practice.
-
Published CMS data list 4,212 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Atorvastatin Calcium — 278 prescription fills, including refills.
- Amlodipine Besylate — 268 prescription fills, including refills.
- Simvastatin — 254 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 78 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 65% of clinicians listed under Internal Medicine in North Miami, FL (2024, 21 clinicians with data). Median for this group: 1,939. Middle half: 140 to 5,286.
More Part D prescriptions than 65% of clinicians listed under Internal Medicine in Florida (2024, 6,545 clinicians with data). Median for this group: 1,318. Middle half: 158 to 5,882.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 7,359 in 2020 to 4,212 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
13377 W Dixie Hwy
North Miami, FL 331614134
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
10,686 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$412,614 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2024
All general payments: $73.04 across 4 records.
By nature of payment
- Food and Beverage: $73.04 across 4 records.
Reporting-company totals
- Amgen Inc.: $58.70 across 3 records.
- Boston Scientific Corporation: $14.34 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2024 (published June 30, 2026).
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Joseph has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Joseph as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in North Miami and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 65% of clinicians listed under Internal Medicine in North Miami, FL (2024, 21 clinicians with data). Median for this group: 1,939. Middle half: 140 to 5,286.
More Part D prescriptions than 65% of clinicians listed under Internal Medicine in Florida (2024, 6,545 clinicians with data). Median for this group: 1,318. Middle half: 158 to 5,882.
Part D drug cost
A higher Part D drug cost than 65% of clinicians listed under Internal Medicine in North Miami, FL (2024, 21 clinicians with data). Median for this group: $205,045. Middle half: $1,368 to $613,530.
A higher Part D drug cost than 70% of clinicians listed under Internal Medicine in Florida (2024, 6,545 clinicians with data). Median for this group: $86,865. Middle half: $8,159 to $434,445.
29 active clinicians are listed under Internal Medicine with a practice address in North Miami, FL (10,165 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in North Miami
37.9% of these 29 clinicians have the CMS telehealth indicator.
48.3% of these 29 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 43% from 7,359 in 2020 to 4,212 in 2024.
- 2020: 7,359
- 2021: 6,502
- 2022: 5,097
- 2023: 3,728
- 2024: 4,212
-
30-day fills
30-day fills decreased 41% from 18,204 in 2020 to 10,686 in 2024.
- 2020: 18,204
- 2021: 15,580
- 2022: 12,466
- 2023: 9,256
- 2024: 10,686
-
Part D drug cost
Part D drug cost increased 21% from $342,255 in 2020 to $412,614 in 2024.
- 2020: $342,255
- 2021: $425,971
- 2022: $388,882
- 2023: $347,569
- 2024: $412,614
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $38.56 in 2019 to $73.04 in 2024.
- 2019: $38.56
- 2021: $40.70
- 2023: $82.42
- 2024: $73.04
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2024), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2024 (payments made January 1 – December 31, 2024): fewer than 11 records totaling $73.04.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
Otezla | General | $21.86 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
Otezla | General | $19.35 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
Otezla | General | $17.49 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
WATCHMAN Access System | General | $14.34 |
Source: CMS Open Payments, program year 2024, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 278 | 24,089 | $2,193.87 | 92 |
| Amlodipine Besylate | Amlodipine Besylate | 268 | 23,427 | $750.60 | 93 |
| Simvastatin | Simvastatin | 254 | 22,187 | $1,314.64 | 77 |
| Metformin Hcl | Metformin Hcl | 246 | 21,603 | $1,222.11 | 76 |
| Nifedipine Er | Nifedipine | 184 | 14,920 | $4,105.58 | 62 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 181 | 15,712 | $2,217.34 | 58 |
| Hydralazine Hcl | Hydralazine Hcl | 155 | 13,220 | $1,459.03 | 60 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 123 | 10,966 | $907.71 | 37 |
| Jardiance | Empagliflozin | 117 | 9,114 | $176,228.97 | 37 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 110 | 9,013 | $2,839.56 | 33 |
| Ibuprofen | Ibuprofen | 92 | 3,343 | $895.94 | 47 |
| Omeprazole | Omeprazole | 92 | 7,575 | $728.26 | 36 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 89 | 8,010 | $984.83 | 31 |
| Lisinopril | Lisinopril | 78 | 6,237 | $346.75 | 25 |
| Pregabalin | Pregabalin | 75 | 2,226 | $343.78 | 25 |
| Glipizide Er | Glipizide | 71 | 6,284 | $1,722.19 | 23 |
| Diclofenac Sodium | Diclofenac Sodium | 69 | 2,139 | $1,566.45 | 26 |
| Losartan Potassium | Losartan Potassium | 65 | 5,730 | $558.80 | 22 |
| Metoprolol Succinate | Metoprolol Succinate | 65 | 5,760 | $878.09 | 23 |
| Zolpidem Tartrate | Zolpidem Tartrate | 64 | 1,967 | $157.26 | 18 |
| Tamsulosin Hcl | Tamsulosin Hcl | 62 | 4,998 | $679.73 | 23 |
| Carvedilol | Carvedilol | 57 | 4,860 | $525.05 | 18 |
| Baclofen | Baclofen | 54 | 2,744 | $404.93 | 26 |
| Furosemide | Furosemide | 53 | 3,279 | $161.33 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 52 | 2,892 | $6,043.33 | 13 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - INTERNAL MEDICINE
I20100811001090
FL
1153455209
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History
NPI enumerated December 14, 2005.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Internal Medicine Providers in North Miami
- Dr. Luis Perez, DO
- Dr. Eliades Carmenate, MD
- Chantal Pina Gomes
- Dr. Stephanie Maryeski, MD, MPH
- Dr. Nasiruddin Nazarally, MD
- Dr. Harpreet Kaur, MD
Mailing Address
13377 W Dixie Hwy
North Miami, FL 331614134
Phone: 3058938306